Companies including Valeant Pharmaceuticals International Inc. and Turing Pharmaceuticals AG have been under fire this year from doctors, patients and lawmakers over rising drug costs. Such increases have prompted investigations by congressional committees, and House Democrats have established a task force to probe drug pricing. On Wednesday, the Senate Special Committee on Aging is scheduled to hold a hearing further exploring the matter.
Read Full Article »
